Search Count: 29
 |
Mycobacterium Tuberculosis Pks13 Acyltransferase Serine Converted To Beta-Lactam Form By Cec215 Via Sufex Reaction
Organism: Mycobacterium tuberculosis h37rv
Method: X-RAY DIFFRACTION Resolution:2.22 Å Release Date: 2025-05-21 Classification: ANTIBIOTIC Ligands: SO4, CL, PG4, EDO, DMS, GOL, PEG |
 |
Mycobaterium Tuberculosis Pks13 Acyltransferase Incubated With Dmso
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2025-05-21 Classification: ANTIBIOTIC Ligands: DMS, SO4, PE5, EDO, PEG, GOL, CL, NA, P33 |
 |
M. Tuberculosis Pks13 Acyltransferase (At) Domain In Complex With Sufex Inhibitor Cec215
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2025-05-07 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 1PE, SO4, A1ATV |
 |
M. Tuberculosis Pks13 Acyltransferase (At) Domain In Complex With Sufex Inhibitor Cmx410
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:2.57 Å Release Date: 2025-05-07 Classification: TRANSFERASE/TRANSFERSE INHIBITOR Ligands: 1PE, SO4, A1ATW |
 |
M. Tuberculosis Pks13 Acyltransferase (At) Domain Sulfate Free Apo Form
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2025-05-07 Classification: TRANSFERASE Ligands: 1PE, SO4 |
 |
M. Tuberculosis Pks13 Acyltransferase (At) Domain In Complex With Sufex Inhibitor Cmx410 - Reaction Product
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2025-05-07 Classification: TRANSFERASE Ligands: SO4, 1PE, A1AVL |
 |
Structure Of Full-Length Amyloidogenic Immunoglobulin Light Chain H9 In Complex With 1-(1-(Imidazo[1,5-A]Pyrazin-8-Yl)Azetidin-3-Yl)-3-(2-(6-Methyl-4-(3-Methyl-3-Phenylpyrrolidin-1-Yl)-2-Oxopyridin-1(2H)-Yl)Ethyl)Urea
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2024-12-18 Classification: IMMUNE SYSTEM Ligands: PO4, A1AHP |
 |
Structure Of Full-Length Amyloidogenic Immunoglobulin Light Chain H9 In Complex With 3-(2-(4-(3-Ethyl-3-Phenylpyrrolidin-1-Yl)-6-Methyl-2-Oxopyridin-1(2H)-Yl)Ethyl)-8-(Imidazo[1,5-A]Pyrazin-8-Yl)-1,3,8-Triazaspiro[4.5]Decan-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-12-18 Classification: IMMUNE SYSTEM Ligands: PO4, A1AH0 |
 |
Structure Of Full-Length Amyloidogenic Immunoglobulin Light Chain H9 In Complex With 2-(6-Methyl-2-Oxo-4-(2-Phenylpropoxy)Pyridin-1(2H)-Yl)Ethyl (3-(1H-Imidazol-4-Yl)Benzyl)Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-12-18 Classification: IMMUNE SYSTEM Ligands: PO4, A1AH2 |
 |
Structure Of Full-Length Amyloidogenic Immunoglobulin Light Chain H9 In Complex With 2-(1-Methyl-3-Oxo-5-(2-Phenylpropoxy)Isoindolin-2-Yl)Ethyl (3-(1H-Imidazol-4-Yl)Benzyl)Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2024-12-18 Classification: IMMUNE SYSTEM Ligands: A1AH6, PO4 |
 |
Structure Of Full-Length Amyloidogenic Immunoglobulin Light Chain H9 In Complex With 4-(3-Ethyl-3-Phenylpyrrolidin-1-Yl)-1,6-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2024-12-18 Classification: IMMUNE SYSTEM Ligands: PO4, A1AH1 |
 |
Structure Of Full-Length Human Lambda-6A Light Chain Jto In Complex With Stabilizer 26 [2-(7-(Diethylamino)-4-Methyl-2-Oxo-2H-Chromen-3-Yl)Ethyl (3-(1H-Imidazol-4-Yl)Benzyl)Carbamate]
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2021-05-19 Classification: IMMUNE SYSTEM Ligands: NY3, PO4 |
 |
Structure Of Full-Length Human Lambda-6A Light Chain Jto In Complex With Stabilizer 34 [3-(2-(7-(Diethylamino)-4-Methyl-2-Oxo-2H-Chromen-3-Yl)Ethyl)-7-(1H-Imidazole-5-Carbonyl)-1,3,7-Triazaspiro[4.4]Nonane-2,4-Dione]
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2021-05-19 Classification: IMMUNE SYSTEM Ligands: PO4, NYO |
 |
Structure Of Full-Length Human Lambda-6A Light Chain Jto In Complex With Stabilizer 36 [3-(2-(7-(Diethylamino)-4-Methyl-2-Oxo-2H-Chromen-3-Yl)Ethyl)-8-(1H-Imidazole-4-Carbonyl)-1,3,8-Triazaspiro[4.5]Decane-2,4-Dione]
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2021-05-19 Classification: IMMUNE SYSTEM Ligands: PO4, NY6 |
 |
Structure Of Full-Length Human Lambda-6A Light Chain Jto In Complex With Stabilizer 62 [4-Methyl-3-(Morpholinomethyl)-7-(1-Phenylethoxy)-2H-Chromen-2-One]
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-05-19 Classification: IMMUNE SYSTEM Ligands: 9ZW, PO4 |
 |
Structure Of Full-Length Human Lambda-6A Light Chain Jto In Complex With Stabilizer 63 [4-Methyl-3-(Morpholinomethyl)-7-(2-Phenylpropoxy)-2H-Chromen-2-One]
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2021-05-19 Classification: IMMUNE SYSTEM Ligands: PO4, 9ZX |
 |
Crystal Structure Of Mouse Sting Ctd Complex With Sr-717.
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2020-08-26 Classification: IMMUNE SYSTEM Ligands: V67 |
 |
Crystal Structure Of Human Sting Ctd Complex With Sr-717
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2020-08-26 Classification: IMMUNE SYSTEM Ligands: V67, GOL, EDO |
 |
Dyrk1A Kinase Domain In Complex With A 6-Azaindole Derivative, Gnf2133.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.70 Å Release Date: 2020-03-04 Classification: TRANSFERASE Ligands: Q8J |
 |
The X-Ray Structure Of Human Prostasin In Complex With A Covalent Benzoxazole Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2008-09-09 Classification: HYDROLASE Ligands: B3C, GOL |